[CAS NO. 214358-33-5]  1400W 2HCl

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [214358-33-5]

Catalog
SLK-S8337
Brand
Selleck
CAS
214358-33-5

DESCRIPTION [214358-33-5]

Overview

MDLMFCD03428622
Molecular Weight250.17
Molecular FormulaC10H15N3.2HCl
SMILESCC(NCC1=CC=CC(CN)=C1)=N.[H]Cl.[H]Cl

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM3.9973 mL19.9864 mL39.9728 mL
5 mM0.7995 mL3.9973 mL7.9946 mL
10 mM0.3997 mL1.9986 mL3.9973 mL
50 mM0.0799 mL0.3997 mL0.7995 mL

Description

1400W (N-(3-(Aminomethyl)benzyl)acetamidine) is a slow, tight binding, and highly selective inhibitor of .

Targets

iNOS [1]
(Cell-free assay)
nNOS [1]
(Cell-free assay)
eNOS [1]
(Cell-free assay)
<7 nM(Kd)2 μM(Ki)50 μM(Ki)

In vitro

1400W is either an irreversible inhibitor or an extremely slowly reversible inhibitor of human iNOS. Inhibition of human iNOS by 1400W is time-dependent. 1400W is competitive with L-arginine. 1400W is not a substrate for iNOS.

In vivo

1400W selectively prevents microvasculature injury in rats. 1400W is greater than 50-fold more potent against iNOS than eNOS in a rat model of endotoxin-induced vascular injury. Moreover, 1400W also dose-dependently reduces LPS-induced vascular leakage associated with iNOS induction in the colon, lung, liver, kidney, and heart. The maximal protection is close to 100% for all organs except the kidney (kidney:54%). 1400W has an ameliorative effect on both oxidative and nitrosative stress in the kidneys against renal I/R injury in rats. Treatment with 1400W can reduce the rate of growth of solid tumors in mice.